Management of Patients Taking GLP-1 Receptor Agonists Prior to Endoscopy

Publication Date: November 7, 2023
Last Updated: November 15, 2023

Summary of Recommendations

There has been increasing concern about performing endoscopic procedures, in particular upper endoscopies, on patients who are using glucagon-like peptide 1 (GLP-1) receptor agonists (GLP-1 RAs) due to their effect on slowing gastric motility and the risk of aspiration of retained gastric contents in sedated patients.

Overview

Title

Management of Patients Taking GLP-1 Receptor Agonists Prior to Endoscopy

Authoring Organization